XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 10,278 $ 5,713
Trade accounts receivable, net of allowance for doubtful accounts of $303 and $346, respectively 31,761 27,779
Inventories, net 42,215 41,192
Prepaid expenses and other current assets 5,949 4,304
Total current assets 90,203 78,988
Property, plant and equipment, net 21,117 21,716
Goodwill 37,571 37,428
Other intangible assets, net 15,107 15,921
Deferred income taxes, net 10,567 12,069
Other noncurrent assets 3,711 2,308
Total assets 178,276 168,430
Current Liabilities:    
Accounts payable 11,336 16,074
Current portion of long-term debt 2,000 2,000
Accrued compensation and related benefits 3,115 2,890
Accrued expenses and other current liabilities 7,279 7,949
Total current liabilities 23,730 28,913
Long-term debt, net 23,624 19,310
Deferred income taxes 1,714 1,917
Other noncurrent liabilities 3,781 1,887
Total liabilities 52,849 52,027
Commitments and Contingencies  
Shareholders' Equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,570,710 shares and 20,522,427 shares, respectively;outstanding – 16,135,358 shares and 16,089,832 shares, respectively 2,078 2,057
Capital in excess of par value 189,160 187,405
Accumulated deficit (40,754) (47,951)
Accumulated other comprehensive loss (3,660) (3,750)
Treasury stock - at cost; 4,435,352 shares and 4,432,595 shares, respectively 21,492 21,484
Total Ultralife Corporation equity 125,332 116,277
Non-controlling interest 95 126
Total shareholders’ equity 125,427 116,403
Total liabilities and shareholders' equity $ 178,276 $ 168,430